CVS Stock Rises as Glenview Capital Plans to Meet Executives

Article's Main Image

CVS Health (CVS, Financial) saw a 2.2% increase in its stock price, closing at $62.73. Hedge fund Glenview Capital Management, which has a roughly 1% stake in CVS Health, is scheduled to meet with the company's executives today to propose improvements in operations.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.